Korro Bio (KRRO) Stock Chart & Stock Price History → These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad) Free KRRO Stock Alerts $62.93 +4.40 (+7.52%) (As of 04/26/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Korro Bio Stock Price Performance5 Day Performance-7.97%1 Month Performance-28.92%3 Month Performance+24.91%Year-To-Date Performance+31.30% Receive KRRO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Korro Bio and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> KRRO Stock Chart for Saturday, April, 27, 2024 KRRO Chart by TradingView Korro Bio Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/26/2024$58.53$62.93+7.52%$63.30$57.1828,091 shs$504.70 million04/25/2024$62.99$58.53-7.08%$63.62$56.2022,991 shs$469.41 million04/24/2024$67.94$62.99-7.29%$67.82$59.9924,767 shs$505.18 million04/23/2024$68.38$67.94-0.64%$72.96$65.0070,404 shs$544.88 million04/22/2024$66.74$68.38+2.46%$70.00$64.5427,831 shs$548.41 million04/19/2024$66.78$66.74-0.06%$67.00$64.2427,616 shs$535.26 million Get the Latest News and Ratings for KRRO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Korro Bio and its competitors with MarketBeat's FREE daily newsletter. 04/18/2024$69.30$66.78-3.64%$70.24$62.0058,828 shs$535.58 million04/17/2024$73.37$69.30-5.55%$75.22$68.7730,285 shs$555.79 million04/16/2024$74.37$73.37-1.34%$75.21$71.3017,794 shs$588.43 million04/15/2024$74.98$74.37-0.81%$75.80$72.0012,857 shs$596.60 million04/12/2024$78.53$74.98-4.52%$79.99$73.4728,533 shs$601.34 million04/11/2024$74.80$78.53+4.99%$80.18$73.0030,276 shs$629.97 million04/10/2024$78.69$74.80-4.94%$79.64$73.2062,844 shs$599.90 million04/09/2024$73.44$78.69+7.15%$80.00$70.5852,837 shs$631.09 million04/08/2024$67.63$73.44+8.59%$73.44$66.5420,902 shs$588.99 million04/05/2024$71.40$67.63-5.28%$73.45$66.8431,248 shs$50.05 million04/04/2024$77.96$71.40-8.41%$79.46$71.4035,028 shs$52.84 million04/03/2024$82.65$77.96-5.67%$82.22$74.0763,952 shs$57.69 million04/02/2024$89.74$82.65-7.90%$91.01$79.2637,987 shs$61.16 million04/01/2024$90.00$89.74-0.29%$90.00$86.9722,341 shs$66.32 million03/29/2024$90.00$90.00$93.00$86.50143,424 shs$66.60 million03/28/2024$88.53$90.00+1.66%$92.91$86.51143,424 shs$66.60 million03/27/2024$86.95$88.53+1.82%$97.91$82.1248,547 shs$65.51 million03/26/2024$73.42$86.95+18.43%$89.00$73.1151,851 shs$64.34 million03/25/2024$65.02$73.42+12.92%$77.61$67.0044,499 shs$54.33 million03/22/2024$65.00$65.02+0.03%$68.98$62.5665,212 shs$48.12 million03/21/2024$64.74$65.00+0.40%$65.42$62.1019,914 shs$48.04 million03/20/2024$64.15$64.74+0.92%$65.00$63.0917,733 shs$47.91 million03/19/2024$61.87$64.15+3.69%$66.26$61.1632,472 shs$47.47 million03/18/2024$61.52$61.87+0.57%$63.50$59.4915,504 shs$45.78 million03/15/2024$59.22$61.52+3.88%$61.52$56.7642,166 shs$45.53 million03/14/2024$53.75$59.22+10.18%$59.22$51.5015,532 shs$43.82 million03/13/2024$55.39$53.75-2.96%$55.00$52.4629,821 shs$39.78 million03/12/2024$56.15$55.39-1.35%$58.35$54.1629,530 shs$40.99 million03/11/2024$55.14$56.15+1.83%$59.39$53.91313,194 shs$41.55 million03/08/2024$49.08$55.14+12.35%$55.14$47.9527,326 shs$40.80 million03/07/2024$49.53$49.08-0.91%$50.88$48.619,007 shs$36.27 million03/06/2024$49.94$49.53-0.82%$50.20$48.4015,970 shs$36.65 million03/05/2024$50.00$49.94-0.12%$50.99$49.1621,634 shs$36.96 million03/04/2024$49.30$50.00+1.42%$51.49$49.8027,559 shs$37 millionBetter than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>>03/01/2024$48.30$49.30+2.07%$51.00$47.7014,988 shs$36.48 million02/29/2024$46.95$48.30+2.88%$49.11$46.6111,093 shs$35.74 million02/28/2024$47.10$46.95-0.32%$48.45$46.2924,273 shs$34.74 million02/27/2024$50.15$47.10-6.08%$54.98$47.1042,054 shs$34.85 million02/26/2024$49.99$50.15+0.32%$50.64$48.7419,009 shs$37.11 million02/23/2024$50.60$49.99-1.21%$51.06$49.3917,915 shs$36.99 million02/22/2024$54.10$50.60-6.47%$55.56$50.6011,085 shs$37.39 million02/21/2024$55.98$54.10-3.36%$58.29$53.1515,715 shs$40.03 million02/20/2024$52.39$55.98+6.85%$56.44$52.1221,280 shs$41.43 million02/19/2024$52.39$52.39$56.80$52.3921,500 shs$38.77 million02/16/2024$53.90$52.39-2.80%$56.80$52.3921,572 shs$38.77 million02/15/2024$54.71$53.90-1.48%$56.80$52.0013,164 shs$39.89 million02/14/2024$53.81$54.71+1.67%$56.99$52.818,284 shs$40.49 million02/13/2024$55.00$53.81-2.16%$58.99$53.026,895 shs$39.82 million02/12/2024$56.90$55.00-3.34%$57.00$54.638,872 shs$40.70 million02/09/2024$58.72$56.90-3.10%$56.96$55.417,293 shs$42.11 million02/08/2024$59.54$58.72-1.38%$59.90$54.675,834 shs$43.45 million02/07/2024$60.11$59.54-0.95%$62.00$57.8514,396 shs$44 million02/06/2024$69.27$60.11-13.22%$69.62$58.7443,277 shs$44.48 million02/05/2024$53.35$69.27+29.84%$69.82$52.0934,206 shs$51.26 million02/02/2024$52.99$53.35+0.68%$53.35$51.363,896 shs$39.48 million02/01/2024$50.81$52.99+4.29%$52.99$49.397,482 shs$39.21 million01/31/2024$49.09$50.81+3.50%$50.81$48.575,289 shs$37.60 million01/30/2024$49.57$49.09-0.97%$49.88$46.5510,267 shs$36.33 million01/29/2024$50.38$49.57-1.61%$50.35$47.3217,684 shs$36.68 million01/26/2024$52.00$50.38-3.12%$51.33$47.9216,698 shs$37.28 million Related Companies: Phathom Pharmaceuticals Stock Price Chart CureVac Stock Price Chart Verve Therapeutics Stock Price Chart Mineralys Therapeutics Stock Price Chart GH Research Stock Price Chart Olema Pharmaceuticals Stock Price Chart AnaptysBio Stock Price Chart Astria Therapeutics Stock Price Chart Nuvation Bio Stock Price Chart Lyell Immunopharma Stock Price Chart Receive KRRO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Korro Bio and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:KRRO) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBiden out June 13; Kamala won’t replace him?Paradigm PressFed launches fourth dollar overhaulStansberry ResearchThe World's First "$20 Trillion Drug?"Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Korro Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.